person

Berta G.

Country
Spain
Department
Pediatrics

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
168
Sites with multiple studies

Has run more than one trial at 168 of 270 partner sites.

Specializations

Acute Lymphoblastic Leukemia Research

This investigator specializes in treating pediatric acute lymphoblastic leukemia (ALL), with particular emphasis on high-risk and relapsed cases. Their expertise extends to Philadelphia chromosome-positive ALL and CD22-positive B-cell precursor ALL treatment approaches.

  • Novel therapeutic strategies for relapsed ALL
  • Immunotherapy applications in pediatric leukemia
  • CAR T-cell therapy development

Their work encompasses innovative cell-based treatments and targeted therapies for resistant disease states.

Acute Myeloid Leukemia Focus

The investigator conducts extensive research in pediatric acute myeloid leukemia (AML), with special attention to FLT3-ITD positive AML and treatment optimization strategies. Their work includes investigation of infection prevention protocols and targeted therapeutic approaches.

  • Risk-stratified treatment protocols
  • Novel induction strategies
  • Infection prophylaxis studies

Their research encompasses comprehensive treatment protocols for children and adolescents aged 0-18 years.

Lymphoma Studies

The investigator's research portfolio includes studies in lymphoblastic lymphoma, focusing on treatment optimization and central nervous system disease prevention. Their work explores various therapeutic intensification strategies.

  • CNS disease prevention protocols
  • Risk-adapted treatment approaches
  • Long-term outcome studies

The research involves international cooperative treatment protocols for pediatric and adolescent patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.